Edition:
United States

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

0.43USD
15 Feb 2019
Change (% chg)

$0.02 (+3.73%)
Prev Close
$0.41
Open
$0.41
Day's High
$0.44
Day's Low
$0.41
Volume
55,174
Avg. Vol
41,741
52-wk High
$1.99
52-wk Low
$0.31

Select another date:

Wed, Dec 26 2018

U.S. drug developer Capricor places Duchenne drug trial on hold

Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

UPDATE 1-U.S. drug developer Capricor places Duchenne drug trial on hold

Dec 26 Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

Capricor places Duchenne drug trial on hold

Dec 26 Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy, a muscle-wasting disorder.

Select another date: